BamSEC and AlphaSense Join Forces
Learn More

Cytokinetics Incorporated – Ownership Summary

NASDAQ: CYTK    
Share price (9/29/26): $65.64    
Market cap (9/29/26): $9.125 billion
Search in Documents
Key Exhibits
External Links

Insider Ownership

≥5% Ownership